References
- Mills S A. Malignant tumors of the heart and pericardium. Thoracic Oncology, J A Roth, J C Ruckdeschel, T H Weisenburger. WB Saunders, Philadelphia 1989; 490–503
- Glancy D L, Roberts W C. The heart in malignant melanoma: A study of 70 autopsy cases. Am J Cardiol 1968; 21: 555–571
- Waller B F, Gottdiener J S, Virmani R, Roberts W C. The “charcoal heart”—Melanoma to the cor. Chest 1980; 77: 671–676
- Dutcher J P, Creekmore S, Weiss G R, Margolin K, Markowitz A B, Roper M A, Parkinson D, Ciobanu N, Fisher R I, Boldt D H, Doroshow J H, Rayner A A, Hawkins M, Atkins M. A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. J Clin Oncol 1989; 7: 477–485
- Mitchell M S, Kan-Mitchell J, Kempf R A, Harel W, Shau H Y, Lind S. Active specific immunotherapy for melanoma: Phase I trial of allogeneic lysates and a novel adjuvant. Cancer Res 1988; 48: 5883–5893
- Kutalek S P, Panidis I P, Kotler M N, Mintz G S, Carver J, Ross J J. Metastatic tumors of the heart detected by two-dimensional echocardiography. Am Heart J 1985; 109: 343–349
- Andreasen A T, Watson F. Experimental cardiovascular surgery. Br J Surg 1952; 39: 548–551